World HIV / AIDS Testing Markets to grow 5.2% to 2014

March 9, 2012 - PRLog -- The report “HIV - AIDS Testing Markets” provides a comprehensive examination of the HIV/AIDS testing market, a specific segment of the in vitro diagnostics (IVD) market as it relates to infectious diseases

According to recent study the HIV/AIDS testing market will grow at 5.2% CAGR to 2014. The chief HIV testing assays, such as predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic, are covered in depth, as are high-growth applications in a major clinical diagnostic areas and expanding markets, such as employee screening, emergency medicine and satellite clinic testing.

The 132 page report covers the following areas in details: enzyme-linked immunosorbent assay (ELISA), antibody/p24 antigen test (fourth-generation test), Western blot assay, line immunoassays, indirect fluorescent antibody (IFA) assay, nucleic acid tests for infectious diseases, and the emerging technologies related to HIV and AIDS diagnosis.

View the report here: http://www.pharmaceutical-market-research.com/publications/diseases_conditions/aids_hiv/hiv_aids_testing_markets.html
Product Code: TRI00134

View more Aids Market Reports at http://www.pharmaceutical-market-research.com/publication...
Pharmaceutical-Market-Research.com, the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.